Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: current status and recommendations for future research.
about
Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies: A convening of the Alzheimer's Association & Alzheimer's Drug Discovery Foundation.Recovery from chemotherapy-induced white matter changes in young breast cancer survivors?Cognitive effects of cancer systemic therapy: implications for the care of older patients and survivors.Monitoring and optimising cognitive function in cancer patients: Present knowledge and future directions.Moderate Physical Activity Mediates the Association between White Matter Lesion Volume and Memory Recall in Breast Cancer SurvivorsCognitive dysfunction after chemotherapy for breast cancer.Modifiable factors and cognitive dysfunction in breast cancer survivors: a mixed-method systematic review.Acute memory deficits in chemotherapy-treated adults.Uric Acid and Neurocognitive Function in Survivors of Childhood Acute Lymphoblastic Leukemia Treated with Chemotherapy Only.Post-traumatic Stress as the Primary Cause for Cognitive Decline-Not the Whole Story, and Perhaps No Story at All.Imaging Brain Networks After Cancer and Chemotherapy: Advances Toward Etiology and Unanswered Questions.Predicting Long-Term Cognitive Outcome Following Breast Cancer with Pre-Treatment Resting State fMRI and Random Forest Machine Learning.In vivo neuroimaging and behavioral correlates in a rat model of chemotherapy-induced cognitive dysfunction.Cerebral functional deficits in patients with ankylosing spondylitis- an fMRI study.Protocol for Exercise Program in Cancer and Cognition (EPICC): A randomized controlled trial of the effects of aerobic exercise on cognitive function in postmenopausal women with breast cancer receiving aromatase inhibitor therapy.Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer
P2860
Q30239964-41228C55-91E6-4BC5-BA11-D10AD95BCCF0Q31155370-A839EE3A-F45B-4027-A123-A1124C96AC19Q34031141-1AD33E59-3C69-4795-9042-58391EC61915Q34604438-BAB3AEDE-F0C6-421E-B948-F6A106A161B5Q35935819-AF5F58A8-6D15-4F4A-97DC-F70B9F0D8453Q38198215-08343D97-EF86-49C1-BD22-A6FD4FAF2DC8Q38594867-6A703E60-6D2E-444E-AF4F-8F21A770F52AQ38747069-453AA49C-FE6F-46E2-88B5-C129703B63D5Q38848380-C02C782D-FF02-4DEB-954B-D2E927152044Q40196382-BE3D474C-7FEB-4BB7-814B-EF14CC8BF608Q42915027-30F9CD2D-1D14-4B43-B747-25BCA0C86D01Q45943432-F0E76F48-1333-41E7-8B3F-904B24C9E48EQ47883693-133E1753-8A93-475A-8624-5BBD02A1AA76Q48631992-BAFE845B-0C95-489D-BE8C-BA74B1CC1C95Q52675767-0B0FA3FE-7859-454F-87B5-3628AF92D294Q57170361-1A496BD2-1205-47D2-87F9-4C04306C8B68
P2860
Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: current status and recommendations for future research.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neuroimaging biomarkers and co ...... endations for future research.
@en
Neuroimaging biomarkers and co ...... endations for future research.
@nl
type
label
Neuroimaging biomarkers and co ...... endations for future research.
@en
Neuroimaging biomarkers and co ...... endations for future research.
@nl
prefLabel
Neuroimaging biomarkers and co ...... endations for future research.
@en
Neuroimaging biomarkers and co ...... endations for future research.
@nl
P2860
P50
P1476
Neuroimaging biomarkers and co ...... endations for future research.
@en
P2093
Daniel H S Silverman
Michiel B de Ruiter
P2860
P2888
P304
P356
10.1007/S11682-013-9283-7
P407
P577
2013-12-01T00:00:00Z